Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion

British Journal of Pharmacology

Volumn 160, Issue 5, 2010, Pages 1234-1242

  Walsh, Sarah K ^a   Hepburn, Claire Y ^a   Kane, Kathleen A ^b   Wainwright, Cherry L ^a  

^a ROBERT GORDON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Arrhythmias; Cannabinoids; Myocardial ischaemia reperfusion injury; Platelets

Indexed keywords

CANNABIDIOL; COLLAGEN; CARDIOTONIC AGENT;

ANIMAL EXPERIMENT; ANTIARRHYTHMIC ACTIVITY; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART PROTECTION; IN VIVO STUDY; MALE; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; THROMBOCYTE AGGREGATION; ANIMAL; ARRHYTHMIAS, CARDIAC; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; MAST CELL; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ARRHYTHMIAS, CARDIAC; CANNABIDIOL; CARDIOTONIC AGENTS; COLLAGEN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAST CELLS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PLATELET AGGREGATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77953198702     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00755.x     Document Type: Article

References (42)

1. Baldassarri S, Bertoni A, Bagarotti A, Sarasso C, Zanfa M, Catani MV et al. (2008). The endocannabinoid 2-arachidonoylglycerol activates human platelets through non-CB1/CB2 receptors. J Thromb Haemost 6 : 1772 1779.
2. Barnes CS, Coker SJ (1995). Failure of nitric oxide donors to alter arrhythmias induced by acute myocardial ischaemia or reperfusion in anaethetized rats. Br J Pharmacol 114 : 349 356.
3. Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I et al. (2001). Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134 : 845 852.
4. Clark C, Foreman MI, Kane KA, McDonald FM, Parratt JR (1980). Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrrhythmias and for the determination of infarct size. J Pharmacol Methods 3 : 357 368.
5. Currie S, Rainbow RD, Ewart MA, Kitson S, Herradon-Pliego E, Kane KA et al. (2008). IP3R-mediated Ca2+ release is modulated by anandamide in isolated cardiac nuclei. J Mol Cell Cardiol 45 : 804 811.
6. Deusch E, Kress HG, Kraft B, Kozek-Langenecker SA (2004). The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets. Anesth Analg 99 : 1127 1130.
7. Durst R, Danenberg H, Gallily R, Beeri R, Mechoulam R, Meir K et al. (2007). Cannabidiol, a non-psychoactive Cannabis constituent protects against myocardial ischemic reperfusion injury. Am J Physiol Heart Circ Physiol 293 : 3602 3607.
8. Flores NA, Goulielmos NV, Seghatchian MJ, Sheridan DJ (1994). Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects. Cardiovasc Res 28 : 1662 1671.
9. Formukong EA, Evans AT, Evans FJ (1989). The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation. J Pharm Pharmacol 41 : 705709.
10. Giudice ED, Rinaldi L, Passarotto M, Facchinetti F, D'Arrigo A, Guiotto A et al. (2007). Cannabidiol, unlike synthetic cannbinoids, triggers activation of RBL-2H3 mast cells. J Leukoc Biol 81 : 1512 1522.
11. 2 receptors in the rat heart. Eur J Pharmacol 579 : 246 252.
12. Hampson AJ, Grimaldi M, Axelrod J, Wink D (1998). Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA 95 : 8268 8273.
13. Hayakawa K, Mishima K, Nozako M, Ogata A, Hazekawa M, Liu AX et al. (2007). Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance. Neuropharmacology 52 : 1079 1087.
14. Honda T, Kaikita K, Tsujita K, Hayasaki T, Matsukawa M, Fuchigami S et al. (2008). Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders. J Mol Cell Cardiol 44 : 915 926.
15. Humphreys RA, Kane KA, Parratt JR (1998). Lack of involvement of mast cell degranulation in the antiarrhythmic effect of preconditioning in rats. J Cardiovasc Pharmacol 31 : 418 423.
16. Krylatov AV, Uzhachenko RV, Maslov LN, Bernatskaya NA, Makriyannis A, Mechoulam R et al. (2002). Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: A possible mechanism. Bull Exp Biol Med 133 : 144 147.
17. Lim SY, Davidson SM, Yellon DM, Smith CC (2009). The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction. Basic Res Cardiol 104 : 781 792.
18. Logue SE, Gustafsson AS, Samali A, Gottlieb RA (2005). Ischemia/reperfusion injury at the intersection with cell death. J Moll Cell Cardiol 38 : 21 33.
19. Maccarrone M, Bari M, Menichelli A, Del Prinipe D, Agro AF (1999). Anandamide activates human platelets through a pathway independent of the arachidonate cascade. FEBS Lett 447 : 277 282.
20. Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R et al. (2000). The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA 97 : 9561 9566.
21. Mamas MA, Terrar DA (1998). Differential sensitivity to cannabidiol of the two components of delayed rectifier potassium currents in guinea pig isolated ventricular myocytes. Br J Pharmacol 123 : 319P.
22. Mechoulam R, Peters M, Murillo-Rodriguez E, Hanus LO (2007). Cannabidiol - recent advances. Chem Biodivers 4 : 1678 1692.
23. Messina A, Knight KR, Dowsing BJ, Zhang B, Phan LH, Hurley JV et al. (2000). Localization of inducible nitric oxide synthase to mast cells during ischemia/reperfusion injury of skeletal muscle. Lab Invest 80 : 423 431.
24. Mishima K, Hayakawa K, Abe K, Ikeda T, Egashira N, Iwasaki K et al. (2005). Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. Stroke 36 : 1077 1082.
25. O'Sullivan SE, Sun Y, Bennett AJ, Randall MD, Kendall DA (2009). Time-dependent vascular effects of cannabidiol in the rat aorta. Eur J Pharmacol 612 : 61 68.
26. Parikh V, Singh M (1997). Resident cardiac mast cells and the cardioprotective effect of ischemic preconditioning in isolated rat heart. J Cardiovasc Pharmacol 30 : 149 156.
27. 9- tetrahydrocannabivarin. Br J Pharmacol 153 : 199 215.
28. Rakhshan F, Day TA, Blakely RD, Barker EL (2000). Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J Pharmacol Exp Ther 292 : 960 967.
29. Russo EB, Burnett A, Hall B, Parker KK (2005). Agnostic properties of cannabidiol at 5-HT1a receptors. Neurochem Res 30 : 1037 1043.
30. 2+ levels. J Neurosci 29 : 2053 2063.
31. Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J et al. (2007). The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152 : 1092 1101.
32. Tamargo J, Caballero R, Gomez R, Valenzuela C, Delpon E (2004). Pharmacology of cardiac potassium channels. Cardiovasc Res 62 : 9 33.
33. 2 receptor agonists in vitro. Br J Pharmacol 150 : 613 623.
34. 2 receptors. Bull Exp Biol Med 131 : 300 302.
35. Underdown NJ, Hiley CR, Ford WR (2005). Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. Br J Pharmacol 146 : 809 816.
36. Vannacci A, Giannini L, Passani MB, Di Felice A, Pierpaoli S, Zagli G et al. (2004). The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of guinea pig mast cells: involvement of nitric oxide and eicosanoids. J Pharmacol Exp Ther 311 : 256 264.
37. Wagner JA, Abesser M, Harvery-White J, Ertl G (2006). 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. J Cardiovasc Pharmacol 47 : 650 655.
38. Wainwright CL, Parratt JR, Bigaud M (1988). The effects of PAF antagonists on ischaemia and reperfusion arrhythmias and ischaemia-induced platelet aggregation. Biomed Biochim Acta 47 : 224 227.
39. Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM et al. (1988). The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 22 : 447 455.
40. Walsh SK, Kane KA, Wainwright CL (2009a). Mast cell degranulation - a mechanism for the anti-arrhythmic effect of endothelin-1? Br J Pharmacol 157 : 716 723.
41. Walsh SK, Kane KA, Wainwright CL (2009b). Mast cells, peptides and cardioprotection - an unlikely marriage? Auton Autacoid Pharmacol 29 : 73 84.
42. Weiss L, Zeira M, Reich S, Slavin S, Raz I, Mechoulam R et al. (2008). Cannabidiol arrests onset of autoimmune diabetes in NOD mice. Neuropharmacology 54 : 244 249.